Community-acquired pneumonia: Difference between revisions
No edit summary |
|||
Line 39: | Line 39: | ||
==Treatment== | ==Treatment== | ||
[[Community-acquired pneumonia medical therapy|Medical Therapy]] | [[Community-acquired pneumonia primary prevention|Primary | [[Community-acquired pneumonia medical therapy|Medical Therapy]] | [[Community-acquired pneumonia primary prevention|Primary Prevention]] | [[Community-acquired pneumonia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Community-acquired pneumonia future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== |
Revision as of 15:39, 10 December 2014
Resident Survival Guide |
Community-Acquired Pneumonia Microchapters |
Differentiating Community-acquired pneumonia from other Diseases |
Diagnosis |
Treatment |
Case Studies |
Community-acquired pneumonia On the Web |
American Roentgen Ray Society Images of Community-acquired pneumonia |
Directions to Hospitals Treating Community-acquired pneumonia |
Risk calculators and risk factors for Community-acquired pneumonia |
For the main page on pneumonia, click here.
For patient information on pneumonia, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: CAP
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Community-acquired pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Criteria for Severe Community-Acquired Pneumonia | CURB-65 Clinical Prediction Rule | Community-acquired Pneumonia Severity Index
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Ultrasound | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies